Medtronic
81
26M
55
1.08
21
0.32
23
- Areas of investment
Summary
In 1949 was created Medtronic, which is appeared as Corporate Investor. The main office of represented Corporate Investor is situated in the Minneapolis. The venture was found in North America in United States.
The top activity for fund was in 2017. Despite it in 2019 the fund had an activity. The fund is constantly included in 2-6 deals per year. When the investment is from Medtronic the average startup value is 50-100 millions dollars. The increased amount of exits for fund were in 2014. Speaking about the real fund results, this Corporate Investor is 13 percentage points more often commits exit comparing to other organizations. The usual things for fund are deals in the range of 10 - 50 millions dollars. Comparing to the other companies, this Medtronic performs on 1 percentage points less the average number of lead investments.
The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the Medtronic, startups are often financed by Johnson & Johnson Development Corporation, Advanced Technology Ventures, U.S. Venture Partners (USVP). The meaningful sponsors for the fund in investment in the same round are Johnson & Johnson Development Corporation, Kleiner Perkins, U.S. Venture Partners (USVP). In the next rounds fund is usually obtained by Johnson & Johnson Development Corporation, U.S. Venture Partners (USVP), New Enterprise Associates.
The fund has specific favorite in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. Among the most popular portfolio startups of the fund, we may highlight Mazor Robotics, Earlens Corporation, AcuFocus. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most successful fund investment fields, there are Biotechnology, Health Care. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.
The fund was created by Daniel Grossman, Earl Bakken, Palmer Hermundslie, Patrick Wells. The overall number of key employees were 26.
Investments analytics
Analytics
- Total investments
- 81
- Lead investments
- 21
- Exits
- 23
- Rounds per year
- 1.08
- Follow on index
- 0.32
- Investments by industry
- Health Care (64)
- Medical Device (51)
- Medical (47)
- Biotechnology (30)
- Therapeutics (15) Show 38 more
- Investments by region
-
- United States (56)
- Israel (9)
- Ireland (2)
- China (7)
- Australia (2) Show 2 more
- Peak activity year
- 2017
- Number of Unicorns
- 2
- Number of Decacorns
- 2
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 16
- Avg. valuation at time of investment
- 110M
- Group Appearance index
- 0.86
- Avg. company exit year
- 12
- Avg. multiplicator
- 3.35
- Strategy success index
- 0.70
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Avation Medical | 01 Feb 2024 | Health Care, Medical Device, Medical, Neuroscience, Mobile Devices, Wearables | Late Stage Venture | 22M | United States, Ohio, Columbus |
| Inspire Medical Systems | 11 May 2012 | Therapeutic Devices, Biotechnology, Health Care, Medical Device, Therapeutics | Late Stage Venture | 14M | United States, Minnesota |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.